Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Are you unconscious? "At AstraZeneca, she was involved in the successful launches of Prilosec®, Nexium®, Crestor® and Iressa®, and managed the hormonal portfolio for AstraZeneca Oncology."
Another loser joins the AVEO scam, right?
https://www.businesswire.com/news/home/20191119005218/en/AVEO-Oncology-Announces-Appointment-Scarlett-Spring-Board/
Sora is shit, BayerMan, and you know it.
Face it, you're not wealthy.
Does AVEO have a KRTX-like move on the horizon? I'm thinking so.
Saturday's presentation hits the wires: https://finance.yahoo.com/news/aveo-announces-presentation-updated-os-110000145.html
It was a joke Kallie. Read some of my posts.
The scam continues with scam artists like Brian Rini weighing in:
Great job @montypal updating TIVO3. Durability of response is interesting for a tki in refractory setting. Tolerability is key in this setting. pic.twitter.com/UCDEN1qGCb
— Brian Rini, MD (@brian_rini) November 16, 2019
Yeah, just 18 still alive on Tivo and 2 on Sora. Nothing positive there. The Sora-polluted crossovers will be explained in the ODAC session after the NDA filing.
Nice trade.
AV-380....according to today's 10Q, they are submitting an IND to the FDA in 2020. An unmet need of gigantic proportions.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104257/
From -$27.2M to +$18.8M in stockholders' equity Q over Q. Holy shit.
$16M net profit for quarter. Those aren't numbers that your typical microcap bio company posts.
What was I saying about Ficlatuzamab? LOL.
If the crossover with the Sora patients hadn't been factored into the trial design, you would have been gone a long time ago. I guess you know that, and kudos for profiting off a bad trial design. But the O/S stats that you claim are worsening are actually improving very quickly now toward the end of the trial. AVEO is not going to submit an NDA if they are not 100% sure that the HR will remain <1. You can take that to the bank, Harry Bayer. AVEO's laid out the path forward for tivozanib in Q1 and Q2 with little room for deviation and don't discount the 50% ORR of the latest Ficlatuzamab trial either.
Post a screenshot of your short trade. I'm sure everyone here would like to see it.
Watch what happens when market opens.
They will be filing the NDA in Q1. Not that big of a delay. The FDA pretty much told them that keeping the HR<1 at the June readout will do it. The HR has been trending down as the data continues to mature,so today's news is positive as the FDA negotiation has set the goal posts.
You mean your posting? Patience is thin, but our rewards will be savored.
Yes we will, and your "fades out" comment will reflect, as I've called, your disappearance when the NDA filing news hits. You're as predictable as a period.
You've been perpetuating this nonsense for years. LMAO.
LMAO! "New rumors" on the floor of your studio apt?
I'm calling BS on that, as well as most everything you post. Once the FDA reverses its January call and greenlights an NDA filing, everything will revert back to the Fall 2017 trading range. Watch.
I am not asking you about "Baily;s Scam." I am asking you if you will be here posting after they announce the NDA submission. Answer the question.
It's a given you'll be posting your nonsense "a lot sooner." That's not what I asked you to do. I asked you to continue posting after AVEO files the NDA. Pretty simple proposition, why the problem understanding it?
The drug works. 18% of patients are alive after 26+ months on the trial. Their pipeline of other drugs is solid as well. Your whales don't play with micro-caps, I get it. That doesn't mean squat. Make sure you are posting here on the day that they file the Fotivda NDA,deal?
"I know several whales very well." What an ignorant post. At any given moment, any major league investment firm can pull the trigger and dive in. It's all about timing for them. Watch your theory on AVEO crumbling to pieces in the coming 6 months completely fall apart. And poof, you'll be nowhere to be found here.
Someone has to mind the store here Harry. One of us will have the ultimate "I told you so" moment here in less than 6 months, and I'm going to enjoy it.
Why is AZN wasting its energy pairing Tivozanib with Durvalumab in a new trial Harry? You'd think they'd avoid a scam company pushing turd drugs.
You're right, it will not meet the O/S of control arm, it will beat it handily. You should have covered at .65 But no, you insist on getting slaughtered. LMAO!
Holding onto the high low for 3 days now, making the run 7 days.
Dark horse Ficlatuzamab is quietly progressing into a Phase3 pancreatic cancer trial after showing outstanding patient response rates and efficacy in Phase1/2. Think there's a big market out there for an effective pancreatic cancer drug?
LOL. 7 days in a row of an uptrending price reversal vs. your call of a dime when it was .65! Should have covered....now you're the truly desperate one. Pigs get slaughtered. LMFAO. NDA acceptance PR right at hand with better stats than EXEL's Cabo and absolutely blowing away the PFS stats of Sora.
Looks like AVEO's posting it's 7th higher low in a row. Did you ever watch Planes, Trains, and Automobiles when John Candy gets on the wrong ramp onto the freeway?? LOL.
A 3.6% increase on today's low from Friday's low. This continues confirming Clay's reversal strength parameter. More nervous "scam" and "turd" laughter is emanating from the peanut gallery. LOL.
Disagree all you want. This past week showed higher lows every day and it only missed posting higher highs on Tuesday and only by a penny. Your analysis on where this PPS is headed is so flawed and skewed by desperation, it's amusing. Should have covered at .65 as those levels are gone. Even Clay admits the floor is .90 now
Like I said, you should have covered at .65
Pigs get slaughtered.
Your system is pretty simple. Monitor the Zacks and Motley Fools' pump articles, look for above average SP movement....coordinate short attack
"Shorting this turd...." Then nervous laughter.
Susquehanna Intnat'l, NEA Mgt, Vanguard, and Millennium Mgt are the latest that do not concur with the "scam" theory.